牛乳房炎市場：タイプ別、製品別、投与経路別、治療法別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析、2025年～2032年

世界の牛乳房炎市場は、2025年には15億6,460万米ドルと推定され、2032年までには22億6,090万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は5.4%で成長すると予測されています。

図.牛乳房炎市場シェア（%）、地域別（2025年）

牛乳房炎は、物理的外傷または微生物が原因の病気の結果として、乳房組織の炎症反応が長引くことを特徴とします。これは生命を脅かす乳腺感染症であり、世界的に乳牛に最も多く見られます。酪農産業の利益率に損害を与える症状として知られています。乳腺炎は、膨大な数の異なる微生物種によって引き起こされます。ウイルス、マイコプラズマ、菌類、および細菌はそれらの中にあります。乳房炎は乳房の赤く固まった塊として現れます。拡大された乳腺は非常に熱く、それに触れることは動物の苦痛そして不快を引き起こします。搾乳を避けるため、動物は乳房を触ったり蹴ったりしません。血栓、悪臭を放つ褐色の分泌物、乳汁の塊はこの状態でよく見られます。

動物の体温が上昇すると、乳汁分泌は停止するか、または著しく妨げられます。食欲不振、乳房肥大による運動障害、痛みも牛乳房炎の症状の一部です。陥没した目、腸の問題、下痢はすべて、牛乳房炎に罹患している酪農動物の症状です。カリフォルニア乳房炎検査（CMT）は、症状が出る前の初期段階（亜臨床期）で乳房炎を診断することができます。少量のミルクで行うことができる簡単な検査です。早期診断により、酪農家にとって大きな損失となる臨床段階への進行を防ぐことができます。

市場力学

世界の牛乳房炎市場の拡大を促進する主な要因のひとつに、世界中で牛乳房炎の有病率が増加していることが挙げられます。例えば、米国国立医学図書館および国立衛生研究所が2020年8月に発表した論文によると、四半期、牛、農場レベルでは、臨床および潜在性乳房炎の全体的な有病率はそれぞれ51.6％（815/1,580）、74.4％（294/395）、76.6％（118/154）でした。

本調査の主な特徴

• 本レポートでは、世界の牛乳房炎市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模および複合年間成長率（CAGR %）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• この調査レポートは、世界の牛乳房炎市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、市場戦略などのパラメータに基づいて掲載しています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• この調査レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界の牛乳房炎市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 世界の牛乳房炎市場の洞察

• 促進要因
• 抑制要因
• 機会
• 影響分析
• パイプライン分析
• 市場動向
• 主な発展
• 技術の進歩
• 製品の発売/承認
• 買収、コラボレーション、契約
• 規制シナリオ
• 疫学
• PEST分析

第4章 世界の牛乳房炎市場 - コロナウイルス（COVID-19）パンデミックの影響

• 経済への影響
• COVID-19疫学
• COVID-19による牛乳房炎市場への影響

第5章 世界の牛乳房炎市場、タイプ別、2020年～2032年

• 臨床的乳腺炎
• 潜在性乳腺炎

第6章 世界の牛乳房炎市場、製品別、2020年～2032年

• 抗生物質
• ワクチン
• 鎮痛剤
• その他

第7章 世界の牛乳房炎市場、投与経路別、2020年～2032年

• 乳房内
• 全身的

第8章 世界の牛乳房炎市場、治療法別、2020年～2032年

• 授乳期
• 乾期
• 抗生物質
• 乳頭シーラント

第9章 世界の牛乳房炎市場、エンドユーザー別、2020年～2032年

• 獣医センター
• 病院
• クリニック
• その他

第10章 世界の牛乳房炎市場、地域別、2020年～2032年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第11章 競争状況

• 企業プロファイル
  • Zoetis
    • 会社のハイライト
    • 製品ポートフォリオ
    • 主なハイライト
    • 財務実績
    • 市場戦略
  • Merck & Co., Inc.
    • 会社のハイライト
    • 製品ポートフォリオ
    • 主なハイライト
    • 財務実績
    • 市場戦略
  • Boehringer Ingelheim International GmbH
    • 会社のハイライト
    • 製品ポートフォリオ
    • 主なハイライト
    • 財務実績
    • 市場戦略
  • Bayer AG
    • 会社のハイライト
    • 製品ポートフォリオ
    • 主なハイライト
    • 財務実績
    • 市場戦略
  • Elanco
  • Ceva
  • West Way Health
  • Norbrook
  • DeLaval
  • ImmuCell Corporation
  • Advanced Animal Diagnostics
  • Nimrod Veterinary Products Ltd

第12章 アナリストの提言

• 運命の輪
• アナリストの見解
• Coherent Opportunity Map

第13章 セクション

• 参考文献
• 調査手法

Global Bovine Mastitis Market is estimated to be valued at USD 1,564.6 Mn in 2025 and is expected to reach USD 2,260.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032.

Figure. Bovine Mastitis Market Share (%), By Region 2025

Bovine mastitis is characterized by a prolonged and inflammatory response of the udder tissue, as a result of either physical trauma or microorganism-caused illnesses. It is a life threatening mammary gland infection that is most prevalent in dairy cows globally. It's a condition known for causing damage on the dairy industry's profit margin. Mastitis is caused by a huge number of different microorganism species. Viruses, mycoplasmas, fungi, and bacteria are among them. Mastitis manifests itself as a red, hardened lump in the udder. The enlarged mammary gland is extremely hot, and even touching it causes pain and discomfort in animals. To avoid milking, animals will not touch or kick the udder. Blood clots, foul-smelling brown discharge, and milk clots are common in this condition.

Milk production comes to a halt or is seriously hampered as the animal's internal temperature rises. Lack of appetite, mobility issues due to a bloated udder, and soreness are some of the other symptoms of bovine mestitis. Sunken eyes, intestinal problems, and diarrhoea are all symptoms among dairy animals suffering from bovine mestitis. California Mastitis Test (CMT) can diagnose mastitis at an early stage (sub-clinical) before symptoms occur. It is a simple test that may be done on little amount of milk. Early identification aids in preventing the disease from progressing to clinical stages, which would result in significant losses for dairy farmers.

Market Dynamics

One of the primary factors driving the global bovine mastitis market expansion include increasing prevalence of bovine mastitis across the world. For instance, according to an article published by the US National Library of Medicine and National Institutes of Health in August 2020, at the quarter, cow, and farm level, the overall prevalence of clinical and subclinical mastitis was 51.6% (815/1,580), 74.4% (294/395), and 76.6% (118/154), respectively.

Key features of the study:

• This report provides in-depth analysis of the global bovine mastitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global bovine mastitis market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies.
• Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global bovine mastitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bovine mastitis market

Detailed Segmentation:

• Global Bovine Mastitis Market, By Type:
  • Clinical Mastitis
  • Sub-clinical Mastitis
• Global Bovine Mastitis Market, By Product:
  • Antibiotics
  • Vaccines
  • Pain Killers
  • Others
• Global Bovine Mastitis Market, By Route of Administration:
  • Intra-mammary
  • Systemic
• Global Bovine Mastitis Market, By Therapy:
  • Lactating Period
  • Dry Period
  • Antibiotics
  • Teat Sealants
• Global Bovine Mastitis Market, By End User:
  • Veterinary Centers
  • Hospital
  • Clinics
  • Others
• Global Bovine Mastitis Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Zoetis
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Elanco
  • Ceva
  • West Way Health
  • Norbrook
  • DeLaval
  • ImmuCell Corporation
  • Advanced Animal Diagnostics
  • Nimrod Veterinary Products Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Therapy
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Market Opportunity Map

3. Global Bovine Mastitis Market Insights

• Drivers
• Restraints
• Opportunity
• Impact Analysis
• Pipeline Analysis
• Market Trends
• Key Developments
• Technological Advancement
• Product Launch/Approvals
• Acquisition, Collaboration & Agreements
• Regulatory Scenario
• Epidemiology
• PEST Analysis

4. Global Bovine Mastitis Market - Impact of Coronavirus (COVID-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact of COVID-19 on Bovine Mastitis Market

5. Global Bovine Mastitis Market, By Type, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clinical Mastitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Sub-clinical Mastitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)

6. Global Bovine Mastitis Market, By Product, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Pain Killers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)

7. Global Bovine Mastitis Market, By Route of Administration, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Intra-mammary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Systemic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million

8. Global Bovine Mastitis Market, By Therapy, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Lactating Period
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Dry Period
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million
• Antibiotics
• Teat Sealants

9. Global Bovine Mastitis Market, By End User, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Veterinary Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Million)

10. Global Bovine Mastitis Market, By Region, 2020 - 2032, (US$ Million)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Region at Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

11. Competitive Snapshot

• Company Profiles
  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elanco
  • Ceva
  • West Way Health
  • Norbrook
  • DeLaval
  • ImmuCell Corporation
  • Advanced Animal Diagnostics
  • Nimrod Veterinary Products Ltd

12. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. Section

• References
• Research Methodology
• About Us and Sales Contact